Jeppe Gram

Jeppe Gram serves as a Clinical Associate Professor within the Department of Regional Health Research at IRS - Esbjerg and Grindsted Hospital's Research Unit of Endocrinology (Esbjerg), affiliated with University of Southern Denmark. His academic profile demonstrates substantial contributions to clinical endocrinology research with 101 documented research outputs including 72 journal articles and numerous conference presentations.

Dr. Gram's research portfolio prominently features diabetes management across multiple dimensions, from investigating coronary flow impairment in type-2 diabetes to evaluating patient-initiated visit models in type-1 diabetes clinics. His work in osteoporosis research has been particularly influential through the decade-long ROSE (Risk-stratified Osteoporosis Strategy Evaluation) randomized trial, which examined systematic population-based screening programs for fracture prevention. Additional significant contributions include research on thyroid disorders, particularly examining selenium supplementation effects in hypothyroidism patients.

Analysis of Dr. Gram's publication history reveals consistent focus on evidence-based clinical interventions with direct patient care implications. His research methodology frequently employs randomized controlled trials and longitudinal study designs, demonstrating expertise in clinical trial execution across multiple endocrine conditions. The work spans both mechanistic investigations of disease processes and practical evaluations of clinical management approaches.

Dr. Gram maintains active professional engagement through editorial work for the Scandinavian Journal of Clinical & Laboratory Investigation and membership in the National Working Group for Specialty Distribution in Endocrinology. His research has secured funding from INTERREG and the Region of Southern Denmark, particularly supporting the ROSE trial initiative.

Collaboration represents a significant aspect of Dr. Gram's work, with research networks extending across Danish institutions including Odense University Hospital and internationally with partners from Lund University and University of Oxford. His fingerprint analysis confirms primary expertise in Non-Insulin Dependent Diabetes Mellitus (100%), Osteoporosis (85%), and Placebo research (58%), reflecting his dominant research themes.